MedWatch

Analyst: Demant's Oticon More generates strong VA figures

Demant's market share of the public US sales channel VA rose to 14.74 percent in May compared to 9.21 percent the month before, which a DNB analyst calls a strong development.

Photo: Thomas Borberg/Politiken/Ritzau Scanpix

Since launching Oticon More on the public US sales channel Veterans Affairs (VA) in May, Demant has gained large market shares for hearing aids.

DNB Equity Analyst Rune Majlund Dahl calls this a "very strong" development.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs